Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.59 -1.05 (-0.86%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.13 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at Evercore ISI HealthCONx Conference Transcript

Nov 28, 2023 / 03:25PM GMT
Release Date Price: $114.49 (-2.59%)
Unidentified Analyst

Thank you guys for being here. Pleasure to have Jazz management join us before we kick things off, maybe I'll turn it over to you Renee to get us going.

Renee D. Gala
Jazz Pharmaceuticals plc - President & COO

Sure. Yes, happy to. Thanks for having us and thank you all for joining us. Just a few housekeeping items. We will be making forward-looking statements today. Please see our website and SEC filings for more information about our business. Should we make reference to financial guidance. We're not updating or reiterating today. All of our guidance is as of Q3 earnings call on November 8. And should we make reference to non-GAAP measures. You can find full reconciliations on our website.

So turning to the business. I'm quite energized by where we are today. The business has been through a complete transformation over the last several years. In 2020, we had about $2.4 billion in revenues, 75% of that was coming from a single product.

Our pipeline was more nascent and R&D capabilities more limited. Looking at where we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot